TCEAL7

Across TCGA pan-cancer cohorts, TCEAL7 RNA differs between tumor and matched normal tissue in 15 of 18 cancer types tested, making tumor–normal expression one of TCEAL7’s most consistent transcriptional readouts.

The strongest signal is observed in kidney chromophobe (KICH), where TCEAL7 RNA is repressed in tumor relative to normal tissue. In most cancer types TCEAL7 is over-expressed in tumor, although a few such as KICH and BLCA show the opposite, repressed pattern.

KICH, BLCA, and COAD are the cancer types where TCEAL7 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in TCEAL7 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KICH	Female	II,III,IV	−2.914	<.001	11	view →
BLCA	All	IV	−2.029	<.001	11	view →
COAD	Male	All	−1.567	<.001	11	view →
KIRC	All	II,III,IV	−0.926	<.001	11	view →
THCA	Female	II,III,IV	−1.206	<.001	10	view →
LUAD	Female	III,IV	−1.707	<.001	9	view →
LUSC	Female	All	−1.543	<.001	8	view →
KIRP	Female	All	−1.664	<.001	7	view →
STAD	All	All	−1.092	.001	7	view →
UCEC	All	III,IV	−3.830	<.001	6	view →
BRCA	Female	All	−2.004	<.001	6	view →
READ	All	All	−2.039	.002	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 15 lineages.

TCEAL7–KICH

Open the KICH breakdown →